These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

482 related articles for article (PubMed ID: 15468596)

  • 1. HIV-1-specific RNA interference.
    Boden D; Pusch O; Ramratnam B
    Curr Opin Mol Ther; 2004 Aug; 6(4):373-80. PubMed ID: 15468596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RNA interference as an antiviral approach: targeting HIV-1.
    Berkhout B
    Curr Opin Mol Ther; 2004 Apr; 6(2):141-5. PubMed ID: 15195925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [RNA interference and its application in inhibiting HIV-1 infection].
    Wei L; Liu X; Cao C
    Sheng Wu Gong Cheng Xue Bao; 2005 Jul; 21(4):516-9. PubMed ID: 16176084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Silencing of HIV-1 with RNA interference: a multiple shRNA approach.
    ter Brake O; Konstantinova P; Ceylan M; Berkhout B
    Mol Ther; 2006 Dec; 14(6):883-92. PubMed ID: 16959541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effective inhibition of hepatitis B virus replication by small interfering RNAs expressed from human foamy virus vectors.
    Sun Y; Li Z; Li L; Li J; Liu X; Li W
    Int J Mol Med; 2007 Apr; 19(4):705-11. PubMed ID: 17334648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computational design of antiviral RNA interference strategies that resist human immunodeficiency virus escape.
    Leonard JN; Schaffer DV
    J Virol; 2005 Feb; 79(3):1645-54. PubMed ID: 15650190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Control of HIV-1 replication by RNA interference.
    Lee NS; Rossi JJ
    Virus Res; 2004 Jun; 102(1):53-8. PubMed ID: 15068880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNAi-inducing lentiviral vectors for anti-HIV-1 gene therapy.
    Liu YP; Westerink JT; ter Brake O; Berkhout B
    Methods Mol Biol; 2011; 721():293-311. PubMed ID: 21431693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection from HIV-1 infection of primary CD4 T cells by CCR5 silencing is effective for the full spectrum of CCR5 expression.
    Butticaz C; Ciuffi A; Muñoz M; Thomas J; Bridge A; Pebernard S; Iggo R; Meylan P; Telenti A
    Antivir Ther; 2003 Oct; 8(5):373-7. PubMed ID: 14640383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonviral vector-mediated RNA interference: its gene silencing characteristics and important factors to achieve RNAi-based gene therapy.
    Takahashi Y; Nishikawa M; Takakura Y
    Adv Drug Deliv Rev; 2009 Jul; 61(9):760-6. PubMed ID: 19386274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of safety and efficacy of RNAi against HIV-1 in the human immune system (Rag-2(-/-)gammac(-/-)) mouse model.
    ter Brake O; Legrand N; von Eije KJ; Centlivre M; Spits H; Weijer K; Blom B; Berkhout B
    Gene Ther; 2009 Jan; 16(1):148-53. PubMed ID: 18668146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The future of HIV infection: gene therapy and RNA interference.
    Delgado R; Regueiro BJ
    Enferm Infecc Microbiol Clin; 2005 Jul; 23 Suppl 2():68-83. PubMed ID: 16373006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific HIV-1 env gene silencing by small interfering RNAs in human peripheral blood mononuclear cells.
    Park WS; Hayafune M; Miyano-Kurosaki N; Takaku H
    Gene Ther; 2003 Nov; 10(24):2046-50. PubMed ID: 14566364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overcoming HIV-1 resistance to RNA interference.
    Boden D; Pusch O; Ramratnam B
    Front Biosci; 2007 May; 12():3104-16. PubMed ID: 17485285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complete knockdown of CCR5 by lentiviral vector-expressed siRNAs and protection of transgenic macrophages against HIV-1 infection.
    Anderson J; Akkina R
    Gene Ther; 2007 Sep; 14(17):1287-97. PubMed ID: 17597795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delivering antiviral siRNA into human T-cells: New approaches in RNAi-based HIV therapy.
    Ban HS; Lee SK; Kumar P
    IDrugs; 2009 Dec; 12(12):774-8. PubMed ID: 19943220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNAi in functional genomics.
    Scherr M; Eder M
    Curr Opin Mol Ther; 2004 Apr; 6(2):129-35. PubMed ID: 15195923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxicogenomics of non-viral drug delivery systems for RNAi: potential impact on siRNA-mediated gene silencing activity and specificity.
    Akhtar S; Benter I
    Adv Drug Deliv Rev; 2007 Mar; 59(2-3):164-82. PubMed ID: 17481774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of HIV replication using RNA interference against HIV-1 integrase.
    Lau TS; Li Y; Kameoka M; Ng TB; Wan DC
    FEBS Lett; 2007 Jul; 581(17):3253-9. PubMed ID: 17592732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lentiviral siRNAs targeting multiple highly conserved RNA sequences of human immunodeficiency virus type 1.
    Chang LJ; Liu X; He J
    Gene Ther; 2005 Jul; 12(14):1133-44. PubMed ID: 15750613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.